X0306 4 2012-09-10 0 0001053369 ELITE PHARMACEUTICALS INC /NV/ ELTP 0001442002 EPIC PHARMA LLC 227-15 NORTH CONDUIT AVE LAURELTON NY 11413-3134 0 0 1 0 Series E Convertible Preferred Stock 0.0244 2012-09-10 4 A 0 250 1000 A 2012-09-10 Common Stock 10245902 2187.5 I see footnote The reporting person, Epic Pharma, LLC ("EP"), is an equity owner of Epic Investments, LLC ("EI"), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer. EP and EI are both owned, wholly or in part, and are operated by Ram Potti, Ashok G. Nigalaye and Jeenarine Narine, each of whom is a director of the issuer. The interest of EP in the securities of the issuer owned by EI is limited, and EP disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI. The right to acquire the Series E Prefered Shares was approved by the issuer's board of directors on March 13, 2009 in connection with a Strategic Alliance Agreement of the same date. N/A Ram Potti 2012-09-10